IVD
IVD (isovaleryl-CoA dehydrogenase, also known as ACAD2 or IVDH) is a mitochondrial matrix flavoenzyme of the acyl-CoA dehydrogenase family. It catalyses the third step of leucine catabolism, converting isovaleryl-CoA to 3-methylbut-2-enoyl-CoA. Browse Assay Genie's current range of IVD research reagents below, or read on for the biology behind the target.
IVD is a mitochondrial matrix enzyme that catalyses the third step in leucine catabolism, in which isovaleryl-CoA (3-methylbutanoyl-CoA) is metabolised to 3-methylbut-2-enoyl-CoA. To a lesser extent, it also participates in the first step of fatty acid beta-oxidation. In this role it catalyses the proR-proR stereospecific alpha,beta-dehydrogenation of other saturated short-chain acyl-CoA thioesters, such as pentanoyl-CoA, hexanoyl-CoA and butanoyl-CoA. The electron transfer flavoprotein (ETF) is the physiological electron acceptor for these reactions.
The IVD protein belongs to the acyl-CoA dehydrogenase family, and HGNC also places it among the flavoproteins. It is a mitochondrial protein, localised to the matrix. The IVD gene is conserved in rodents, with orthologues named Ivd in both mouse and rat, which supports the use of rodent models in studies of branched-chain amino acid metabolism. Alternatively spliced transcript variants have been reported for the human gene.
IVD has also been called ACAD2 and IVDH, and earlier names include isovaleryl Coenzyme A dehydrogenase. Its clinical relevance comes from genetic deficiency. Loss of IVD function results in an accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. For researchers, IVD is therefore a useful marker of leucine breakdown and a reference point for the wider acyl-CoA dehydrogenase family. Studies of IVD, whether by antibody-based detection, ELISA or other immunoassays, usually focus on mitochondrial function and inborn errors of metabolism.
IVD catalyses the third step of leucine breakdown, making it a central enzyme for studying branched-chain amino acid metabolism.
Genetic IVD deficiency causes isovaleric acid to accumulate, which is toxic to the central nervous system and leads to isovaleric acidemia.
IVD contributes to the first step of beta-oxidation of short-chain acyl-CoA thioesters, using ETF as its electron acceptor.
As a matrix flavoenzyme of the acyl-CoA dehydrogenase family, IVD is a model for studying mitochondrial dehydrogenase function.
IVD is a mitochondrial matrix enzyme that catalyses the third step in leucine catabolism, converting isovaleryl-CoA to 3-methylbut-2-enoyl-CoA. It also contributes, to a lesser extent, to fatty acid beta-oxidation by dehydrogenating short-chain acyl-CoA thioesters, using electron transfer flavoprotein as the electron acceptor.
IVD stands for isovaleryl-CoA dehydrogenase. Aliases and previous symbols include ACAD2 and IVDH, and earlier names include isovaleryl Coenzyme A dehydrogenase. NCBI notes that alternatively spliced transcript variants have been found for this gene.
Genetic deficiency of IVD causes accumulation of isovaleric acid, which is toxic to the central nervous system and leads to isovaleric acidemia. The gene has mouse and rat orthologues, both named Ivd. Check the datasheet of any product for its validated reactivity.
Other acyl-CoA dehydrogenases, electron transfer flavoproteins and mitochondrial metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P26440; product specifications from Assay Genie datasheets.